OTL38 Injection (OTL38) for Intra-Operative Imaging of Folate Receptor Positive Ovarian Cancer
Clinical trial NCT04941378 · WITHDRAWN
Trial details
- NCT number
- NCT04941378
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-28
- Primary completion
- 2022-05-28
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.